Home | By sponsor

CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title Date of Registrationsort icon State
NeuroEPO in patients with Mild-Moderate Alzheimer's disease 01/02/2017 Registered
NeuroEPO in patients with Parkinson disease stage II-III 01/02/2017 Registered
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma 01/09/2016 Registered
Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. 01/10/2020 Registered
NeuroEPO in stroke 02/08/2018 Registered
Phase I/II trial with the mutein no alfa of IL-2 03/02/2017 Registered
CIMAvax-EGF-Platelets-Adults- Lung Cancer 03/08/2018 Registered
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase I 03/11/2017 Registered
Dose scale-up and cohort expansion with the therapeutic mAb 14F7 04/12/2015 Registered
CIMAVax EGF in Lung Cancer in PHC. Phase IV 05/08/2014 Registered
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma 05/09/2017 Registered
Nimotuzumab cold kit for the immunodiagnosis of solid tumors 05/10/2018 Registered
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma 05/11/2013 Registered
14F7 in chronic B-cell lymphoproliferative syndrome 07/03/2018 Registered
NGcGM3/VSSP in small cell lung cancer 07/12/2016 Registered
NGcGM3/VSSP in Metastatic melanoma 07/12/2016 Registered
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer 08/07/2015 Registered
VSSP in metastasic renal cell carcinoma 08/08/2018 Registered
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 08/10/2015 Registered
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory 09/07/2018 Registered